Skip to search formSkip to main contentSkip to account menu

BMS 181101

Known as: BMS-181101 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PiperazinesPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Sensitive triple-quadrupole mass spectrometric assay for the determination of BMS-181885, a 5-HT1 agonist, in human plasma following solid phase extraction.
A sensitive, selective, accurate, precise and reproducible triple-quadrupole liquid chromatographic-mass spectrometric assay was… 
1998
1998
Pharmacokinetic Assessment of the Sites of First‐pass Metabolism of BMS‐181101, an Antidepressant Agent, in Rats
The relative contribution of the gut and the liver to the first‐pass metabolism of BMS‐181101 (3‐[3‐[4‐(5‐methoxy‐4‐pyrimidinyl… 
1997
1997
Lack of effect of food on the steady state pharmacokinetics of BMS‐181101, an antidepressant, in healthy subjects
The effect of food on the pharmacokinetics of BMS‐181101, a new anti‐depressant under development, was investigated in 12 healthy… 
1997
1997
Effects of age, gender, and diurnal variation on the steady‐state pharmacokinetics of BMS‐181101, an antidepressant, in healthy subjects
1996
1996
Effects of Age, Gender and Diurnal Variation on the Steady‐State Pharmacokinetics (PK) of BMS‐181101
Clinical Pharmacology & Therapeutics (1996) 59, 202–202; doi: 10.1038/sj.clpt.1996.306 
1996
1996
High-performance liquid chromatographic-ultraviolet assay for the simultaneous quantitation of BMS-181101 and its putative hydroxy metabolites in rat and monkey plasma.
A specific, accurate, precise, and reproducible High-performance liquid chromatographic-Ultraviolet (HPLC-UV) method was… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)